- 全部删除
- 您的购物车当前为空
我们很想知道您的意见反馈,所以我们在每个页面上都梳理出一个反馈按钮。
SCR-1481B1 (c-Met inhibitor 2) 能够作用于依赖 Met 激活的癌症,对 VEGFR 具有抑制作用。
SCR-1481B1 (c-Met inhibitor 2) 能够作用于依赖 Met 激活的癌症,对 VEGFR 具有抑制作用。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 282 | In stock | |
5 mg | ¥ 745 | In stock | |
10 mg | ¥ 1,230 | In stock | |
25 mg | ¥ 2,150 | In stock | |
50 mg | ¥ 3,570 | In stock | |
100 mg | ¥ 4,970 | In stock | |
200 mg | ¥ 6,870 | In stock | |
1 mL x 10 mM (in DMSO) | ¥ 1,120 | In stock |
产品描述 | SCR-1481B1 (c-Met inhibitor 2) has activity against cancers dependent on Met activation and also has activity against cancers as a VEGFR inhibitor |
别名 | 麦他替尼胺丁三醇, c-Met inhibitor 2 |
分子量 | 821.12 |
分子式 | C32H40ClF2N6O13P |
CAS No. | 1174161-86-4 |
Smiles | NC(CO)(CO)CO.NC(CO)(CO)CO.Nc1nccc(Oc2ccc(NC(=O)c3cn(COP(O)(O)=O)cc(-c4ccc(F)cc4)c3=O)cc2F)c1Cl |
密度 | no data available |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||
溶解度信息 | DMSO: 31 mg/mL (37.75 mM), Sonication is recommended. | |||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||
DMSO
|
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
评论内容